A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL)

CDKN2A is the major melanoma susceptibility gene so far identified, but only 40% of three or more case families have identified mutations. A comparison of mutation detection rates was carried out by “blind” exchange of samples across GenoMEL, the Melanoma Genetics Consortium, to establish the false...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Harland, Mark, Goldstein, Alisa M, Kukalizch, Kairen, Taylor, Claire, Hogg, David, Puig, Susana, Badenas, Celia, Gruis, Nelleke, Huurne, Jeanet ter, Bergman, Wilma, Hayward, Nicholas K, Stark, Mitchell, Tsao, Hensin, Tucker, Margaret A., Landi, Maria Teresa, Scarra, Giovanna Bianchi, Ghiorzo, Paola, Kanetsky, Peter A., Elder, David, Mann, Graham J, Holland, Elizabeth A, Bishop, D Timothy, Bishop, Julia Newton
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2008
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2494985/
https://ncbi.nlm.nih.gov/pubmed/18394881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejca.2008.03.005
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak